Derivation Web

source_945bebcc13614e97

**Selected angle:** `source`

## One-sentence thesis

The cited direct receipts support a bounded working claim: Gastrointestinal adverse events were more frequent with semaglutide (82.8%) vs placebo (63.2%); Gastrointestinal events were reported in 49.1% of participants who continued subcutaneous semaglutide vs 26.1% with placebo.


**Interpretation note:** This is a hypothesis-generating alpha m…